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Bradykinesia is a well-documented DOPA-responsive clinical feature of Parkinson’s dis-
ease (PD). While amplitude deficits (hypokinesia) are a key component of this slowness,
it is important to consider how dopamine influences both the amplitude (hypokinesia)
and frequency components of bradykinesia when a bimanually coordinated movement is
required. Based on the notion that the basal ganglia are associated with sensory deficits,
the influence of dopaminergic replacement on sensory feedback conditions during biman-
ual coordination was also evaluated. Bimanual movements were examined in PD and
healthy comparisons in an unconstrained three-dimensional coordination task. PD were
tested “off” (overnight withdrawal of dopaminergic treatment) and “on” (peak dose of
dopaminergic treatment), while the healthy group was evaluated for practice effects across
two sessions. Required cycle frequency (increased within each trial from 0.75 to 2 Hz), type
of visual feedback (no vision, normal vision, and augmented vision), and coordination pattern
(symmetrical in-phase and non-symmetrical anti-phase) were all manipulated. Overall, coor-
dination (mean accuracy and standard deviation of relative phase) and amplitude deficits
during bimanual coordination were confirmed in PD participants. In addition, significant
correlations were identified between severity of motor symptoms as well as bradykinesia
to greater coordination deficits (accuracy and stability) in PD “off” group. However, even
though amplitude deficits (hypokinesia) improved with dopaminergic replacement, it did
not improve bimanual coordination performance (accuracy or stability) in PD patients from
“off” to “on.” Interestingly, while coordination performance in both groups suffered in the
augmented vision condition, the amplitude of the more affected limb of PD was notably
influenced. It can be concluded that DOPA-responsive hypokinesia contributes to, but is not
directly responsible for bimanual coordination impairments in PD. It is likely that bimanual
coordination deficits in PD are caused by the combination of dopaminergic system dys-
function as well as other neural impairments that may be DOPA-resistant or related to
non-dopaminergic pathways.
Keywords: bimanual coordination, motor control disorders, dopamine, bradykinesia, hypokinesia, Parkinson’s
disease
INTRODUCTION
Bradykinesia is a well-documented clinical feature of Parkinson’s
disease (PD) that is characterized by progressive reduced frequency
and/or amplitude (hypokinesia) of movements (1, 2). Bradykine-
sia responds well to dopamine replacement (2, 3), with amplitude
(hypokinesia) being a key contributor to these improvements
(4). Several researchers have demonstrated that, in addition to
bimanual coordination deficits (i.e., decreased accuracy and/or
stability), slower and smaller movements were also present during
auditory-cued bimanually coordinated movements in PD (5–8).
The presence of bimanual coordination deficits in individuals
with PD supports the notion that the basal ganglia contribute
to the execution of coordinated movements. Furthermore, based
on these previous studies, it is plausible that bimanual coordina-
tion deficits in individuals with PD may be caused by amplitude
and/or frequency deficits. If this were the case, one might pre-
dict that dopaminergic replacement therapy in individuals with
PD should improve these components of bradykinesia and conse-
quently coordination. Interestingly, since auditory cues have been
demonstrated to influence only temporal aspects of auditory-cued
movement (9), and given that previous coordination studies (men-
tioned above) have identified amplitude deficits in metronome-
cued coordination tasks, we hypothesized that DOPA-responsive
amplitude deficits in PD may have a significant contribution to
cued bimanual coordination.
Although an association between the dopaminergic system,
bradykinesia, and bimanual coordination deficits is possible, sev-
eral studies have shown slower (10) and smaller movements (6,
10, 11) during bimanual coordination in individuals with PD
independent of coordination impairments., yet this has not been
verified with a true within-subject“on”–“off”dopaminergic study.
In our previous study, it was demonstrated that slowness in the
time needed to plan a switch between coordination phase pat-
terns but not coordination in itself was improved with dopamine
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replacement (12). This study provided support that dopaminer-
gic pathways may differentially influence slowness in planning
from slowness in execution of bimanual coordination. While it
is known that bradykinesia may refer to slowness in programing
or executing a movement (13), the current study intended to clar-
ify whether specific spatiotemporal aspects of bradykinesia during
coordinated movement (such as amplitude) would also respond to
dopaminergic treatment, without influencing coordination itself.
It is possible that the deficits in coordination cannot fully be
explained by dopaminergic system dysfunction since the basal
ganglia are part of a distributed network involved in bimanual
coordination that includes the supplementary motor area (SMA),
cerebellum, primary motor cortex, premotor cortex, cingulate cor-
tex, and primary sensorimotor area identified through functional
imaging research (14–18). As a consequence, dopaminergic system
dysfunction may only have a small contribution to bimanual coor-
dination impairments in individuals with PD and alternatively,
may be associated with disperse neural impairments.
Coordination impairments in PD may also be caused by sen-
sorimotor integration deficits (19, 20). To support this viewpoint,
Schettino et al. (21) manipulated visual feedback, object shape,
and dopamine replacement while PD participants coordinated a
unimanual reach-to-grasp movement. It was found that PD partic-
ipants had slower movements and disrupted intralimb coordina-
tion during hand preshaping that was related to deficits in integrat-
ing proprioceptive and visual information compared to healthy
older adults. Furthermore, dopamine replacement improved the
speed of movement but did not ameliorate hand preshaping, sug-
gesting that coordination impairments may be caused by a deficit
in the integration of visual and proprioceptive information that
are independent of the hypodopaminergic pathways (21). Thus,
it is important to consider how sensory integration deficits may
be influenced by the dopaminergic system during coordinated
movements.
Alternatively, increased attentional and cognitive demands may
negatively influence coordination performance as suggested by
Almeida et al. (22). Increased attentional demands may involve
performing anti-phase coordination (23, 24) or the combina-
tion of anti-phase with the presence of external auditory cueing
(5). The negative relationship between attention and coordina-
tion could be related to difficulties in shifting attention or limited
attentional resources that have been proposed for individuals with
PD when performing simultaneous tasks (12, 25, 26). Importantly,
it has been argued that executive dysfunction related to attention
may be mediated by neural mechanisms that are not responsive to
dopamine replacement (27–29). Research by Riekkinen et al. (30)
compared the effects of dopamine replacement and noradrenalin
(clonidine) replacement on different attention tasks in individuals
with PD. It was found that dopamine replacement improved the
speed of movement but had no effect on attention itself, leading the
authors to conclude that attentional processes are not influenced
by dopamine replacement in PD (30). Although bradykinesia
improves with dopamine replacement, it is possible that bimanual
coordination deficits may be caused by other neural impairments
related to attention or sensorimotor integration pathways that can-
not be corrected with dopamine replacement. If this were true,
then bimanual coordination deficits in individuals with PD would
not be caused by slowness or amplitude deficits. Thus, a secondary
aim of the current study was to evaluate how conditions that might
be associated with sensory-attentional networks might respond to
dopamine replacement during coordination.
The primary objective of the current study was to determine
the contribution of the dopaminergic system to bimanual coor-
dination in individuals with PD while challenging various neural
pathways through the manipulation of visual feedback, coordina-
tion pattern, and required cycle frequency. Manipulating these fac-
tors allowed the evaluation of two hypotheses: (1) If dopaminergic
system dysfunction causes coordination deficits then coordination
impairments would be observed in association with frequency or
amplitude deficits in individuals with PD compared to healthy
older participants after withdrawal of dopamine replacement (PD
“off”). Importantly, dopamine replacement would improve fre-
quency of movement and/or amplitude and coordination impair-
ments in individuals with PD; (2) If bimanual coordination deficits
were related to other neural impairments such as attention or
sensorimotor integration pathways, then manipulating the sen-
sory feedback to be attended to, to maintain the required cycle
frequency and/or coordination demands would result in impair-
ments in coordination performance in individuals with PD, inde-
pendent of frequency or amplitude deficits and subsequently
dopamine replacement.
MATERIALS AND METHODS
PARTICIPANTS
Initially, 15 (n= 15, mean age= 68± 6.3, range 52–77 years)
adults with a confirmed diagnosis of idiopathic PD were recruited
to participate in this study. PD patients were diagnosed accord-
ing to UK Brain Bank Criteria as confirmed by a movement
disorders specialist, as well as each patient’s personal neurolo-
gist (at the time of enrollment into our research center’s data-
base, see below). In addition, 11 age-matched (n= 11, mean
age= 64.8± 6.4, range 55–75) participants without any neuro-
logical impairment were investigated as healthy comparisons. All
individuals were right-hand dominant based on responses to the
Waterloo Handedness Questionnaire (WHQ) (31). To verify that
all individuals had the cognitive ability to perform the experi-
ment and were free from dementia, they were assessed on the
Modified Mini Mental State Examination (3-MS) (32) with previ-
ously verified cut-off score of 81 out of 100 (33) (see Table 1 for
demographic information including 3-MS scores). All PD (mean
3-MS= 94.1± 5.2, range 83–100) and healthy comparison partic-
ipants (mean 3-MS= 96.7± 3.8, range 89–100) scored above the
criterion.
Parkinson’s disease participants were assessed for motor sever-
ity on the motor subsection of the Unified Parkinson’s Disease
Rating Scale (UPDRS-III) (34) both with (“on”) and without
(“off”) dopamine replacement. Since the goal of the current study
was to evaluate the influence of bradykinesia (frequency and
amplitude deficits) on bimanual coordination, four PD partici-
pants with the lowest overall severity as well as bradykinesia were
excluded from coordination, amplitude, and frequency analyses
(see Table 2, participants 4, 8, 10, and 11). These participants were
removed to avoid mild and potentially low DOPA-responsive clin-
ical features that would have confounded the primary objective of
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Table 1 | Demographic information of healthy comparison and PD participants.
Participant Group1 Age (in years) Gender2 3-MS (out of 100)3 Education (in years) Time between session (in min)4
1 PD 52 F 100 14 90
2 PD 62 F 96 12 90
3 PD 72 M 96 16 75
4* PD 77 M 98 20 70
5 PD 67 M 91 12 75
6 PD 67 F 92 10 70
7 PD 76 M 93 12 70
8* PD 69 M 88 10 90
9 PD 63 F 100 20 75
10* PD 66 F 98 12 70
11* PD 72 M 100 21 75
12 PD 65 F 98 15 70
13 PD 75 F 83 10 70
14 PD 67 F 91 15 70
15 PD 70 M 88 18 85
16 HC 74 M 100 18 65
17 HC 65 F 99 16 75
18 HC 63 F 100 15.5 70
19 HC 75 F 93 16 70
20 HC 67 M 97 14 80
21 HC 58 M 92 15 75
22 HC 62 M 99 18.5 80
23 HC 68 F 89 10 70
24 HC 58 F 100 16 70
25 HC 68 M 100 12 70
26 HC 55 F 95 16 70
1PD, Parkinson’s disease participants; HC, healthy comparison participants.
2M, male; F, female.
33-MS represents the modified Mini Mental State Examination.
4Time between sessions is equivalent to time “on” medication for PD participants.
*Denotes PD participants that were included in correlation analyses but removed from all other analyses of coordination, movement amplitude, and frequency.
the current study. As a consequence, a sub-sample of 11 PD par-
ticipants (n= 11, mean age= 66.9± 6.7, range 52–76 years) were
included in coordination, amplitude, and frequency analyses. In
addition to evaluating motor severity, the UPDRS-III was also used
to confirm responsiveness of motor signs to dopaminergic med-
ications in PD patients. All individuals with PD were confirmed to
have a minimum five-point difference in motor severity as assessed
between “off” and “on” scores on the UPDRS-III. Assessment “off”
(mean UPDRS-III= 30.6± 8.6, range 18.5–46) occurred after
overnight withdrawal from all dopaminergic treatments (mean
time “off”= 14.9± 1.8 h, range 12–18). After completion of the
first session, PD participants self-administered their regular dosage
of medications and were re-examined on the UPDRS-III to rep-
resent “on” state (mean time “on”= 76.3± 8.1 min, range 70–90).
Total daily levodopa equivalent dose (LED) were calculated for
each participant as previously suggested (35). To determine which
upper limb was more affected by PD, upper limb laterality scores
were calculated and compared for both limbs from items 20–25 on
the UPDRS-III that evaluates upper limb motor symptoms, sim-
ilar to previous research (36–38). Based on these laterality scores,
individuals with PD were also classified as bilaterally affected if
both sides summed to five (or above) or were separated by less than
one point. This was necessary to allow completion of any analyses
comparing the amplitude and frequency deficits associated with
the more and/or less affected limb. Session two was then com-
pleted in their “on” state (mean UPDRS-III= 20.0± 7.9, 10–35.5)
(see Table 2 for clinical characteristics). Furthermore, to investi-
gate if practice effects were present between the first and second
sessions, all of the healthy comparison participants also performed
two sessions (mean time between= 72.3± 4.7 min, range 65–80).
Individuals were excluded from the study if they had any recent
injury to their upper limbs that would influence their ability to
perform the task, uncorrected vision (including uncorrected mac-
ular degeneration, cataracts, or glaucoma) or uncorrected hearing.
Additionally, participants were excluded if they had previous his-
tory of stroke or serious brain trauma. Individuals with PD were
included regardless of tremor, dyskinesia, or freezing but as pre-
viously mentioned, patients with low severity were excluded to
avoid excessively mild motor signs (i.e., bradykinesia). All PD par-
ticipants were recruited from the patient database at the Sun Life
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Table 2 | Clinical characteristics of PD participants.
Participant Duration
since
diagnosis
(in
years)1
Duration
since first
reported
symptoms
(in years)1
Dopamine
medications2
Total daily
levodopa
equivalent
dose (LED)
(mg)3
Time “off”
medication
(h)
UPDRS-III
“off”
(out of 108)4
Time “on”
medication
(min)
UPDRS-III
“on”
(out of 108)4
Difference
in UPDRS
“off” and
“on”
Disease
laterality3
1 9 10 LD–CD 900 13.5 27 90 13.5 13.5 R<L
2 5 6 LD–CD 1000 12 46 90 35.5 10.5 L<R
3 8 10 LD–CD 300 15.5 30.5 75 22 8.5 L<R
4* 4 6 LD–CD 200 14.5 20 70 12.5 7.5 L<R
5 11 11 LD–CD, ras,
pram
1450 13.5 31 75 22 9 R<L
6 6 6 LD–CD 900 18 42.5 70 22.5 20 R<L
7 9 9 LD–CD, tri,
pram
1200 15 38 70 30.5 7.5 L<R
8* 1 3 LD–CD 300 15 21 90 14.5 6.5 L<R
9 2 6 LD–CD 400 12.5 32 75 23 9 L<R
10* 8 11 LD–CD, ent,
ras
499 16.5 18.5 70 10 8.5 L<R
11* 0.5 1 LD–CD, ent 1023 16 21.5 75 12.5 9 L<R
12 4 5 LD–CD, pram 275 14.5 34 70 23 11 R<L
13 4 5 LD–CD 400 13.5 41.5 70 30.5 11 R<L
14 4 4 LD–CD 300 17 26.5 70 10.5 16 L<R
15 5 6 rop, ras 340 17 29.5 85 17.5 12 R<L
1Information obtained from patient history on database. Duration since diagnosis was always reported. Duration since first symptoms was reported as duration since
diagnosis if not reported differently by patient.
2LD–CD, levodopa–carbidopa (L-DOPA/DOPA decarboxylase inhibitor); ras, rasagiline (MAO-B selective agent); pram, pramipexole (dopamine receptor agonist); ent,
entacapone (COMT inhibitors); rop, ropinirole (dopamine receptor agonist); tri, trihexyphenidyl (antimuscarinic).
3Total daily levodopa dose (LED) was calculated using the formulas provided by Tomlinson et al. (35).
4UPDRS-III scores represent clinical evaluation on the motor subsection of the Unified Parkinson’s Disease Rating Scale. Disease laterality was based on the sum of
scores on the right side compared to the left side.
*Denotes PD participants that were included in correlation analyses but removed from all other analyses of coordination, movement amplitude, and frequency.
Financial Movement Disorders Research and Rehabilitation Cen-
tre (MDRC) at Wilfrid Laurier University. Healthy comparison
participants were recruited from family and friends of the PD
participants. Ethics for this study was granted from the Research
Ethics Board (REB) at Wilfrid Laurier University. Written con-
sent was obtained from all participants prior to initiation of
experimental testing.
APPARATUS
To perform the bimanual wrist flexion-extension movements, two
robotic Phantom Omni haptic devices (SensAble Technologies
Inc., Woburn, MA, USA) were used according to a previously pub-
lished protocol [see Figure 1 and refer to (12) for full description
of the apparatus].
PROTOCOL
Each participant performed the protocol in two sessions within
a single day. Participants coordinated their wrists in flexion-
extension movements as previously described [please see (12)
for specific details of the typical protocol employed in our lab,
including practice trials details].
Before each trial began, participants were instructed to coor-
dinate their limbs in either in-phase or anti-phase. In-phase and
anti-phase have both been shown to be intrinsic, stable coordina-
tion patterns commonly performed by the human motor system
and have often been used to evaluate bimanual coordination from
the perspective of motor control (39–43). In-phase was performed
as a symmetrical pattern that required simultaneous flexion and
extension of the wrists. This coordination required the synchro-
nized use of homologous muscles in both limbs and a relative phase
goal of 0° or 360° (44). Anti-phase was performed as an asymmet-
rical pattern that had participants simultaneously flex one wrist
and extend the other wrist. This phase pattern required the use of
non-homologous musculature in each limb and a relative phase
goal of 180° (44).
Visual feedback was manipulated to permit three sensory feed-
back conditions: (i) no vision eliminated vision by blindfolding
participants; (ii) normal vision allowed participants to see their
wrist movements with the Omni devices; (iii) augmented vision
eliminated vision of the moving limbs by covering the arms and
required participants to use the augmented visual feedback on the
computer monitor.
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FIGURE 1 | Experimental set-up including Phantom Omni Devices,
forearm constraints, and computer monitor with augmented
feedback display. During testing, individuals forearms were held in
place by the forearm constraints lined with foam padding and grasped
the white and blue pen-shaped attachment in their hand with their
thumbs on top.
The combination of phase and sensory manipulations cre-
ated six conditions. Each condition was performed in a pseudo-
randomized order three times for a total of 18 trials per session.
Each testing session lasted approximately 1.5 h including set-up,
UPDRS-III and 3-MS assessments, and testing protocol. Rest was
provided when needed to reduce fatigue.
DATA PROCESSING, DEPENDENT MEASURES, AND ANALYSIS
The customized software program (Matlab R2007b) recorded and
stored displacement data from all three dimensions at a rate of
1000 Hz per second from each of the Omni devices. Data analysis
was performed on medial-lateral displacement using a customized
script (Matlab R2007b).
While there were instances where coordination during anti-
phase became very uncoordinated and approached in-phase, there
was rarely any clear and sustained spontaneous phase transi-
tions (based on evaluation of the displacement data). This has
been commonly reported, and thus, none of these trials would
have been removed from analysis. However, freezing episodes did
occur slightly more frequently. Approximately 36 trials involved
clear freezing episodes across all participants, and hence were
excluded from analysis. In order to evaluate and analyze the freez-
ing episodes more closely, as well as the conditions that may have
led to freezing episodes, further analysis (including EMG during
episodes) will be required and reported elsewhere (since they do
not contribute to the objectives of the current manuscript).
Coordination accuracy and stability
The calculation of the relative phase (position of one limb rel-
ative to the other) was used to evaluate coordination accu-
racy and stability. The relative phase was determined from the
position of one limb relative to the other using the well-described
formula (39):
Relative phase (θ) = tan−1 [(dXR/dt ) /XR]
However, since phase relationships could range from 0 to 360°,
a linear transformation was performed on the relative phase to
obtain values from 0 to 180° using the formula:
New relative phase (θn) = 180− (relative phase (θ)− 180)
Absolute error (AE) of the relative phase (θn) was calculated
from the absolute difference between the average relative phase
and the intended movement phase. An intended in-phase pattern
would be quantified by a relative phase of 0° and an anti-phase
pattern would be represented by 180° of relative phase. Mean and
standard deviation of the AE of θn was determined for each cycle
frequency interval during every trial then calculated across groups.
Amplitude
The amplitude of each limb was measured independently to eval-
uate the spatial component of the movement. Specifically, this
measure was used to evaluate if any amplitude deficits, represen-
tative of the hypokinesia component of bradykinesia, existed in
individuals with PD. The amplitude was determined from each
cycle of movement using the formula:
Amplitude (cm) = Amplitude Peakmax (cm)
− Amplitude Peakmin (cm)
www.frontiersin.org July 2013 | Volume 4 | Article 89 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Almeida and Brown Hypokinesia and coordination in PD
The mean amplitude of each limb was determined from aver-
aging the amplitude of each peak during each cycle frequency
interval for every trial then averaged across each group.
Performed cycle frequency
The performed cycle frequency of each limb was calculated to
evaluate the temporal component of the movement. This mea-
sure was used to evaluate if any frequency deficits, representative
of frequency component of bradykinesia, existed in individuals
with PD. The performed cycle frequency was calculated using the
movement cycles (positive to subsequent positive peak) during a
given time interval using the formula:
Cycle frequency (Hz) = number of cycles/time (s)
The mean performed cycle frequency of each the right and left
limb was determined at each cycle frequency interval for every trial
then averaged across each group.
Statistical analyses
Statistical analyses were performed using Statistica 8 (StatSoft Inc.,
Tulsa, OK, USA). t -Tests were performed on age, 3-MS scores, edu-
cation, and time between sessions to verify that if any differences
existed between PD and healthy comparison participants. Addi-
tionally, a paired t -test was performed on UPDRS-III scores of PD
“off” and PD “on.”
In order to evaluate if a relationship existed between motor
symptom severity and coordination performance, separate Pear-
son correlational analyses compared mean coordination accuracy
and stability of relative phase for their association with motor
symptom severity in both PD “off” and “on” (see Table 4). In
addition, Pearson correlational analyses were also performed to
evaluate the association between bradykinesia (score derived from
items 23, 24, 25, 26, and 31 of the UPDRS-III) and mean coordi-
nation performance (accuracy and stability of relative phase) for
both PD “off” and “on.” Mean coordination accuracy and stability
were calculated across all manipulations of conditions, phase, and
performed cycle frequency for each PD participant. In contrast
to analyses of coordination, amplitude, and frequency, all 15 PD
participants were included in the correlations since the goal of
these analyses was to evaluate how disease severity was associated
to coordination performance.
To analyze coordination accuracy (mean relative phase)
and stability (standard deviation of relative phase), a mixed-
model (between and within-group) ANOVA was designed with
group (PD, healthy comparisons) as the between-group fac-
tor and within-group factors: session (one, two), condition
(no vision, normal vision, augmented vision)× phase (in-phase,
anti-phase)× required cycle frequency (0.75, 1, 1.25, 1.5, 1.75,
2 Hz). Mean amplitude and performed cycle frequency were
analyzed using a mixed-model ANOVA designed with between-
group factors (PD, healthy comparisons) and within-group fac-
tors: session (one, two)× limb (more affected/matched limb, less
affected/matched limb)× condition (no vision, normal vision, aug-
mented vision)× phase (in-phase, anti-phase)× required cycle
frequency (0.75, 1, 1.25, 1.5, 1.75, 2 Hz). Limb was treated as a fac-
tor allowing comparison between the more and less affected limbs
in PD (see Table 2) and matched hands in healthy comparison
group. Hands were matched based on age and gender when
possible.
In order to evaluate our specific hypotheses, planned com-
parisons were made for the dependent variables (see Table 3).
Specifically, to determine the effects of basal ganglia dysfunction
on coordination performance, amplitude, and frequency, planned
comparisons were performed on session 1 using group (PD “off,”
healthy comparisons) as the between-group factor. To evaluate the
effects of dopamine replacement on coordination accuracy, coor-
dination stability, amplitude, and frequency, planned comparisons
were performed between session one (PD “off”) and session two
(PD “on”) of PD participants. Finally, a planned comparison was
performed on session one compared to session two of healthy com-
parison participants based on the overall mixed-model design to
determine if any practice effects existed for coordination accuracy
and stability. A complete list of all between- and within-group fac-
tors for each dependent measure in each planned comparison is
presented in Table 3.
In all cases, an alpha level of 0.05 was used to define statistical
significance. Tukey’s HSD post hoc analysis was used to investigate
any significant interactions that were revealed from the ANOVA
analyses.
RESULTS
COMPARISON OF DEMOGRAPHIC VARIABLES
Student’s t -tests revealed that there were no significant differ-
ences between PD and healthy comparison participants when
considering age, self-reported education, amount of time between
sessions and 3-MS scores (see Table 4). The UPDRS-III scores were
found to be significantly different (mean difference= 11.6± 3.7)
between PD “off” (mean UPDRS “off”= 34.4± 6.6) and PD “on”
(mean UPDRS “on”= 22.8± 7.4) [t (10)= 10.5, p< 0.001].
PEARSON CORRELATIONAL ANALYSES BETWEEN MOTOR SYMPTOM
SEVERITY AND BRADYKINESIA TO COORDINATION PERFORMANCE
(ACCURACY AND STABILITY)
A significant correlation was revealed between the severity of
motor symptoms (as revealed by UPDRS-III) in PD “off” partic-
ipants and the mean coordination accuracy across all conditions
[r(15)= 0.48, p< 0.05] (see Figure 2A). In addition, the mean
variability in coordination across all conditions was significantly
correlated to the degree of severity of motor symptoms in PD“off”
[r(15)= 0.58, p< 0.01] (see Figure 2B). Furthermore, significant
correlations were identified between overall bradykinesia scores
and both mean coordination accuracy [r(15)= 0.78, p< 0.01] and
mean variability in coordination [r(15)= 0.83, p< 0.01] across all
conditions. In contrast, the correlations between motor symptom
severity or bradykinesia and coordination performance in PD“on”
were not significant.
PD “OFF” VS. HEALTHY COMPARISON PARTICIPANTS
All significant main (and interaction) effects that are superseded by
significant interaction effects are not described in detail. In addi-
tion, only significant interactions involving group are presented
herein. Please see Table A1 (coordination accuracy and stabil-
ity) and Table A3 (amplitude and performed cycle frequency) in
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Table 3 | Description of statistical comparisons.
ANOVA planned
comparisons
Dependent
measures
Between-group
factor
Within-group
factors
Dependent
measures
Between-group
factor
Within-group
factors
PD “off” vs. healthy
comparisons
Coordination
accuracy and
coordination stability
Group Condition, phase,
required cycle
frequency
Amplitude and
performed cycle
frequency
Group Limb, condition,
phase, required
cycle frequency
PD “off” vs. PD “on” Coordination
accuracy and
coordination stability
N/A Session, condition,
phase, required
cycle frequency
Amplitude and
performed cycle
frequency
N/A Session, condition,
phase, required
cycle frequency
HC session 1 vs.
session 2
Coordination
accuracy and
coordination stability
N/A Session, condition,
phase, required
cycle frequency
Table 4 | Statistical comparisons of age, education, 3-MS, and time
between sessions of PD and healthy comparison (HC) participants.
PD (n=11) HC (n=11) t Statistic (df)
and p-value
Age (in years) 66.9 (±6.7) 64.8 (±6.43) t (20)=−0.74,
p=0.46
3-MS (out of 100) 93.5 (±5.2) 96.7 (±3.9) t (20)=1.67,
p=0.11
Self-reported education
(in years)
14.0 (±3.2) 15.2 (±2.5) t (20)=0.97,
p=0.34
Time between sessions
(in min)
76.4 (±8.1) 72.3 (±4.7) t (20)=−1.5,
p=0.16
Appendix for complete statistical results of significant main effects
and interactions. Interactions that did not reach significance are
not reported.
Coordination accuracy
A significant interaction between group, phase, and required cycle
frequency was revealed [F(5, 100)= 2.83, p< 0.05]. As illustrated
in Figure 3, Tukey’s post hoc analysis revealed that healthy compar-
ison participants had greater coordination accuracy in anti-phase
at the fastest required cycle frequencies (1.75 and 2 Hz) com-
pared to PD “off” participants. Additionally, PD “off” participants
had greater coordination accuracy during in-phase at 0.75 and
1 Hz compared to 2 Hz and during anti-phase at 0.75 and 1 Hz
compared to 1.5, 1.75, and 2 Hz. In contrast, healthy comparison
participants had greater coordination accuracy during anti-phase
at 0.75 and 1 Hz compared to 2 Hz but no difference in coordina-
tion accuracy during in-phase coordination at any required cycle
frequency. In addition, a significant main effect of condition was
found [F(2,40)= 5.41,p< 0.01]. Tukey’s post hoc analysis demon-
strated greater coordination accuracy when coordinating in no
vision and normal vision relative to the augmented vision condition.
Coordination stability
A significant interaction between group and phase was revealed
[F(1, 20)= 10.19, p< 0.01]. Tukey’s post hoc revealed that both
FIGURE 2 | Correlationanalyses revealing that higher motor severity in
PD patients “off” (as measured by UPDRS-III) was associated with (A)
greater coordination error (absolute error of relative phase, degrees)
and (B) greater coordination variability (standard deviation of absolute
error of relative phase, degrees). Red circles highlight the four least
severe PD patients that were removed from all other analyses.
PD “off” and healthy comparison participants had more variable
coordination in anti-phase compared to in-phase, but the healthy
participants had significantly less variable coordination in anti-
phase compared to PD “off.” In addition, there were also a signifi-
cant interaction for group, condition, and required cycle frequency
[F(10, 200)= 2.45, p< 0.01]. Tukey’s post hoc did not reveal any
significant differences between PD “off” and healthy compari-
son participant but revealed that there was less variability at the
two slowest required cycle frequencies (0.75 and 1 Hz) and coor-
dination became increasingly more variable at each subsequent
required cycle frequency interval particularly in augmented vision
relative to no vision and normal vision.
Mean amplitude (affected/less affected limbs PD “off” compared to
matched limbs)
There were a significant interaction between group and required
cycle frequency [F(5, 100)= 8.0, p< 0.001]. As illustrated in
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FIGURE 3 | Mean absolute error of relative phase (degrees) compared
between PD “off” and healthy comparison (HC) participants as a
function of phase (in-phase= IP and anti-phase=AP) and cycle
frequencies. Results showed that HC had more accurate coordination
compared to PD “off” participants at faster cycle frequencies (1.25–2 Hz) in
anti-phase (bars denote standard error). *Denotes significant differences
between HC and PD “off” participants.
FIGURE 4 | Mean amplitude (cm) of limb movements compared
between PD “off” and healthy comparison (HC) participants as a
function of cycle frequencies. Results showed that larger movement were
produced by HC participants compared to PD “off” at all cycle frequencies.
Figure 4, Tukey’s post hoc analysis showed that the healthy older
participants were performing larger movements with both limbs
compared to PD “off,” particularly at the fastest required cycle
frequencies (1.25, 1.5, 1.75, and 2 Hz). Interestingly, PD “off”
did not change amplitude regardless of increasing required cycle
frequency. There was also a significant main effect of phase [F(1,
20)= 14.8, p< 0.01] demonstrating larger amplitude movements
were produced with both limbs during in-phase compared to
anti-phase coordination.
Disease laterality in PD participants was shown to affect ampli-
tude as revealed by a significant interaction between group, limb,
and condition [F(2, 40)= 17.9, p< 0.01]. Tukey’s post hoc analysis
showed that the less affected limb in PD participants had larger
movements in all conditions compared to the more affected limb.
In addition, both groups had larger movements in both limbs in
normal vision compared to no vision, and no vision compared to
augmented vision.
Mean performed cycle frequency (affected/less affected in PD “off”
compared to matched hands in healthy comparisons)
There was a significant interaction between group, limb, and
required cycle frequency [F(5, 100)= 3.5, p< 0.01]. Tukey’s
post hoc analysis indicated that the performed cycle frequency
in both limbs was not different at any required cycle frequency
between PD “off” and healthy comparisons. In both groups, as
required frequency increased, the cycle frequency in both limbs
increased except healthy control participants maintained cycle
frequency between 1.25 and 1.5 Hz in both limbs.
PD “OFF” VS. PD “ON”
All significant main (and interaction) effects that are superseded by
significant interaction effects are not described in detail. In addi-
tion, only significant interactions involving session are presented
herein. Please see Table A2 (coordination accuracy and stabil-
ity) and Table A4 (amplitude and performed cycle frequency) in
Appendix for complete statistical results of significant main effects
and interactions. Interactions that did not reach significance are
not reported.
Coordination accuracy
A main effect of condition was found [F(2, 20)= 4.2, p< 0.05]
that revealed coordination was more accurate in normal vision
compared to augmented vision. There was no significant influ-
ence (main effect or interactions) of dopamine replacement on
coordination accuracy.
Coordination stability
A significant main effect of condition was found [F(2, 20)= 3.7,
p< 0.05] that demonstrated coordination was less variable with
normal vision compared to augmented vision. Similar to coordi-
nation accuracy, there was no influence of dopamine replace-
ment (significant main effect or interactions) on coordination
variability.
Mean amplitude (More affected compared to less affected)
The influence of disease laterality and dopamine replacement on
amplitude was revealed by a significant interaction between ses-
sion, limb, and required cycle frequency [F(5, 50)= 2.8, p< 0.05].
As illustrated in Figure 5, Tukey’s post hoc analysis indicated that
PD “off” produced larger movements in the most affected limb at
slower cycle frequencies (0.75 to 1.25 Hz) compared to PD “on.”
Similarly, larger movements were produced in the least affected
Frontiers in Neurology | Movement Disorders July 2013 | Volume 4 | Article 89 | 8
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Almeida and Brown Hypokinesia and coordination in PD
FIGURE 5 |The influence of dopamine replacement on mean amplitude
(cm) of the more and less affected limb in PD participants across cycle
frequencies. Results demonstrated that PD “on” had larger amplitude
movements at the faster cycle frequency in the less affected limb.
However, PD “off” had larger amplitude movements in the more and less
affected limb at slower cycle frequencies (0.75–1 and 1 Hz, respectively)
(bars denote standard error). *Denotes significant differences between PD
“off” and PD “on.”
limb at 1 Hz in PD “off” compared to PD “on.” In contrast, at
the fastest cycle frequency (2 Hz) PD “on” had larger amplitude
movements in the less affected limb compared to PD “off.” PD
“off” produced larger movements in the least affected limb at all
required cycle frequencies compared to the more affected limb. In
contrast, PD “on” produced larger movements in the least affected
limb at the faster cycle frequencies (1.25–2 Hz) compared to the
more affected limb.
Mean performed cycle frequency (More affected compared to less
affected)
Unlike amplitude, dopamine replacement did not have an influ-
ence (significant main effect or interactions) on performed cycle
frequency of either limb.
HEALTHY COMPARISON PARTICIPANTS – EFFECTS OF PRACTICE
All significant main (and interaction) effects that are superseded
by significant interaction effects are not described in detail. In
addition, only significant interactions involving session are pre-
sented herein. Please see Table A5 in Appendix for all significant
main effects and interactions. Interactions that did not reach
significance are not reported.
Coordination accuracy
No significant influence (main effect or interactions) of ses-
sions was revealed for coordination accuracy in the healthy older
participants.
Coordination stability
There was a significant interaction between session and condition
[F(1, 10)= 4.3, p< 0.05]. Tukey’s post hoc analysis revealed that
there was less variability when coordinating with augmented vision
in session two compared to session one. Additionally, coordina-
tion was less variable during normal vision compared to augmented
vision in session one but not session two.
DISCUSSION
The primary objective of the current study was to evaluate the
DOPA-responsiveness of specific spatiotemporal aspects of move-
ment (such as amplitude and frequency) that contribute to move-
ment slowness during bimanual coordination. Previous research
demonstrated that the ability to initiate a switch between coor-
dinated movements was improved with dopamine replacement
(12). Given that PD typically presents with unilateral ampli-
tude and frequency of movement deficits (which are generally
responsive to dopamine replacement), it was hypothesized that
if bimanual coordination deficits in PD were primarily related
to amplitude (hypokinesia) and/or frequency deficits, that both
coordination and these clinical features would be ameliorated
with dopaminergic replacement. Alternatively, if deficits in biman-
ual coordination were associated with other DOPA-resistant or
non-dopaminergic neural impairments, then amplitude and fre-
quency components of movement would be expected to respond
to dopamine alone, while deficits in coordination would be
independent DOPA-responsive clinical features of movement.
The main finding of the current study was that both biman-
ual coordination impairments and movement amplitudes deficits
were identified between PD “off” compared to healthy com-
parison participants. However, even though these amplitude
deficits (hypokinesia) improved with dopaminergic treatment
during clinical assessment, and also while coordinating the less
affected limb at faster cycle frequencies, bimanual coordination
impairments did not. Taken together with our previous find-
ings, dopamine appears to improve both limb amplitude during
coordinated movement (i.e., hypokinesia), as well as the speed at
which a switch in plans for different coordination patterns can
be achieved, while initiation and the bimanual coordination in
itself does not improve. It should be noted however that cor-
relational analyses in the current study revealed that bimanual
coordination deficits were associated with the severity of dopamin-
ergic system dysfunction as well as overall bradykinesia, suggesting
that disease progression and bradykinesia contribute, but are not
primarily responsible for bimanual coordination impairments in
PD. The results support our alternative hypothesis that DOPA-
resistant neural impairments (or potentially impairments in non-
dopaminergic pathways) have a key contribution to bimanual
coordination deficits in PD.
DOPAMINERGIC SYSTEM AND BRADYKINESIA (HYPOKINESIA) DURING
COORDINATED MOVEMENTS IN PD
Typically, anti-phase compared to in-phase coordination is per-
formed with greater error and variability at the faster cycle fre-
quencies in adults (41, 45). The current study found that PD
“off” dopaminergic treatment had significantly worse coordina-
tion accuracy during anti-phase at faster cycle frequencies (1.75
and 2 Hz) as well as more variable coordination in anti-phase com-
pared to healthy older adults. These results support previous find-
ings that individuals with PD have greater difficulty coordinating
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their limbs in anti-phase particularly as frequency of movement
approaches 2 Hz as compared to young and older adults (5, 7, 11,
24). Imaging research examining anti-phase coordination in PD
demonstrated different connectivity as well as hypoactivation in
the SMA-proper as a consequence of dopamine loss (46). As sug-
gested by Johnson et al. (24), the difficulty for individuals with PD
to bimanually coordinate in asymmetrical anti-phase movements
may be associated to the disruption in the thalamocortical path-
way to the SMA leading to a breakdown in the precise sequential
muscle activation of homologous muscles. Thus, understanding
how the amplitude and frequency components of the movement
were affected may help to clarify the breakdown in coordination
in PD.
Since no differences were identified between individuals with
PD and healthy for the movement frequency of each limb, we can
conclude that PD maintained the appropriate cycle frequency (i.e.,
performed cycle frequency) similar to healthy. This is in agreement
with previous studies that have found that auditory cueing (com-
pared to removal of cues) is useful for maintaining the correct cycle
frequency of movement in PD during bimanual coordination (11,
24). In addition, auditory cues were found to result in less vari-
able cycle times, amplitudes, and coordination during bimanual
circle drawing tasks in PD, young, and elderly participants (47). It
has been argued that individuals with PD have an impaired ability
to internally regulate timing of repetitive movements especially
at faster frequencies (36, 48–51). In view of the fact that individ-
uals with PD were maintaining the correct cycle frequency with
the metronome, it would suggest that attention was directed at
synchronizing movements with the external cues to compensate
for internal timing deficits. Based on the current results, external
timing cues were sufficient to reduce the effects of bradykinesia
(i.e., slowness) and as a consequence, dopamine replacement did
not influence the performed cycle frequency during bimanually
coordinated movements in individuals with PD. Thus, the fre-
quency component of bradykinesia does not appear to contribute
to coordination deficits in PD during externally cued bimanual
coordination.
In regards to amplitude of movement, PD “off” had signifi-
cantly smaller amplitudes compared to healthy participants pre-
dominantly at faster cycle frequencies (1.25–2 Hz). Furthermore,
significant correlations were identified between overall bradykine-
sia and coordination impairments in PD “off.” This would suggest
that amplitude deficits may have contributed to coordination
impairments in PD. However, a key novel finding of the current
study was that even though amplitude in the less affected limb and
amplitude modulation was improved with dopamine replacement
(representative of improvements in bradykinesia with dopamine
replacement during movement execution), neither coordination
accuracy nor stability was influenced by dopaminergic modula-
tion. In the current study, healthy elderly participants increased
the amplitude of their movements with increased cycle frequency
but PD “off” patients did not follow this trend. PD “off” par-
ticipants maintained similar amplitudes of movement as cycle
frequency increased. In healthy adults, simultaneously increases in
amplitude of movements are often observed with cycle frequency
increases due to the greater forces and velocities being applied
by the faster moving limbs (52, 53). Considering the performed
cycle frequency was modulated appropriately, the amplitude mod-
ulation of movements appears to be constrained in the PD “off”
group during auditory-cued bimanual movements. However, even
in the PD “on” group where amplitude modulation was improved
a mismatch between limbs still existed. The deficits in amplitude
modulation as well as different movement amplitudes in the limbs
likely contributed to an amplitude interference effect that has
been previously reported in bimanual coordination tasks in young
healthy adults when they required to produce different movement
amplitudes in each limb (54, 55). Thus, even when dopaminergic
treatment in PD “on” improves the size of movements in the least
affected limb at faster cycle frequencies and improves amplitude
modulation, the amplitude mismatch between the limbs is still
present in PD likely contributing to coordination impairments
in PD.
The lack of contribution of dopamine replacement to coor-
dination performance is in agreement with the hypothesis that
bimanual coordination impairments are influenced by a distrib-
uted neural network (14–18) rather than a direct and causal
relationship to limb asymmetries in the amplitude of bimanually
coordinated movements. It was previously suggested that specific
aspects of movements speed (such as amplitude) may normalize
with dopaminergic treatment, while parameters that depend on
precise and different patterns of neuronal firing such as timing and
coordination are not restored with dopamine replacement (56).
Thus, other DOPA-resistant neural impairments related to PD
likely contribute to bimanual coordination deficits in PD patients.
Since PD is known to affect many different neural pathways outside
the dopaminergic system such as the cholinergic, noradrenergic,
and serotonergic systems throughout its’ progression as revealed
by the Braak system (57), it is likely that these neural impairments
also contribute to bimanual coordination deficits in PD.
RELATIONSHIP BETWEEN ATTENTION, SENSORIMOTOR INTEGRATION,
AND COORDINATION IN PD
It was proposed as an alternative hypothesis, that bimanual coor-
dination deficits in individuals with PD may be associated with a
more disperse neural dysfunction involving attentional or senso-
rimotor integration processes. Since PD participants were able to
maintain the required cycle frequency for each limb in the cur-
rent task, it is likely that attentional resources were directed to the
external auditory cues. Furthermore, anti-phase coordination has
been shown to require a greater attentional load than in-phase
coordination (58). It is possible that the presence of these external
auditory cues particularly during anti-phase coordination nega-
tively influenced coordination performance in PD as suggested
by our previous research (5, 12). It has previously been suggested
that individuals with PD may have difficulty shifting attention
or limited attentional resources during simultaneous tasks (12, 25,
26). Research has shown that attentional impairments are resistant
to dopaminergic treatment but respond to clonidine (noradrena-
line) in PD (30). It may be possible that individuals with PD lack
the attentional resources or ability to shift attention at the faster
cycle frequencies with external cueing when having to perform
anti-phase coordination.
Furthermore, the manipulation of sensory feedback conditions
allowed the investigation of whether sensorimotor integration
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deficits might contribute to coordination deficits in PD. The results
of the current study did not provide conclusive evidence to support
sensorimotor integration problems as a key influence on bimanual
coordination. Although coordination performance (both accuracy
and variability) was worse, with smaller movement amplitudes
during the augmented vision condition (compared to normal vision
and no vision conditions), no coordination differences existed
between groups. Furthermore, the more affected limb in PD
patients produced smaller amplitude movements compared to the
least affected limb, particularly in augmented vision, but a similar
effect was not reflected in coordination performance. Thus, while
specific aspects of movement control appear to be affected by the
availability of sensory feedback, coordination does not appear to
be directly affected by sensory feedback manipulations.
Difficulties in sensorimotor integration in PD are usually
observed during slow voluntary movements (20) such as self-
paced reach-to-grasp movements (21, 59) or fast internally reg-
ulated rhythmic movements (56), rather than fast externally cued
movements used in the current study. It was expected that indi-
viduals with PD would demonstrate greater deficits compared
to healthy older adults using augmented visual feedback since
previous research has demonstrated that variability of coordi-
nation in PD participants did not improve after training with
augmented visual feedback (60). Furthermore, PD have been
shown to undershoot the amplitude of movement when they are
unable to see their moving limb (61) as was the case with the aug-
mented visual feedback used in the current study. Furthermore,
PD patients have marked deficits in visuo-motor coordination
that has been linked to disrupted parietal-premotor circuits (62,
63). However, augmented visual feedback led to similar impair-
ments in coordination in PD and healthy older adults suggesting
that it was not the cause of coordination deficits in PD. Since
both PD and healthy older adults had near equal difficulty in
coordinating with augmented visual feedback, it is likely that all
individuals have difficulty making visuo-motor transformations
of the limbs into a single representation of their coordinated
movements.
It is important to note that healthy older adults demonstrated a
significant improvement in coordination variability in the aug-
mented vision condition across sessions. Unlike healthy older
adults, PD participants were unable to benefit from augmented
visual feedback. No improvements were seen in PD across sessions
regardless of practice or dopamine replacement. It has previously
been suggested that PD are impaired in learning (28, 64–66). Fur-
thermore, it was argued that learning is influenced by dopamin-
ergic modulation (64, 66). Feigin et al. (66) found that learning
motor sequences was impaired in PD patients after administra-
tion of dopamine replacement. Jahanshahi et al. (64) proposed
that the tonic release of dopamine with dopamine replacement
therapy impairs the phasic release of dopamine that is essential
for learning. Impaired motor learning in individuals with PD
could be an alternative explanation for the current results, in the
sense that motor learning was not able to occur between sessions
due to the administration and subsequent influence of dopamine
replacement. However, PD participants did not demonstrate more
variable coordination in the augmented vision condition relative
to healthy elderly participants, which suggests that this did not
contribute to the current results. Nevertheless, the influence of
dopamine replacement on motor learning needs to be carefully
considered in future research when examining PD patients across
sessions.
POTENTIAL NEURAL MECHANISMS OF BIMANUAL COORDINATION
IMPAIRMENTS IN PD
The neural mechanism that may be responsible for bimanual
coordination impairments during cued anti-phase coordination
are likely complex due to the distributed neural networks that
are involved in these types of movements (15, 16). Tradition-
ally, impairments in anti-phase bimanual coordination have been
associated with hypoactivation in the SMA due to basal ganglia
dysfunction (24, 46). However due to the distributed neural net-
work involved in bimanual coordination, dysfunction in pathways
linking the basal ganglia to other neural structures such as the
anterior cingulate cortex (ACC) or dorsolateral prefrontal cor-
tex (DLPFC) may also be involved. The ACC has been argued
to be involved in inhibiting unwanted or competing movement
responses during bimanual movements (15). In this view, dysfunc-
tion in the pathways involving the ACC may lead to a decreased
ability to inhibit competing responses during bimanual coordi-
nation such as homologous muscles in anti-phase coordination.
Another possible candidate is the attentional system. Imaging
research has identified that PD have decreased functional connec-
tivity between DLPFC and basal ganglia with the SMA during anti-
phase coordination (46). The DLPFC has been associated with the
frontoparietal (top–down) attentional system, that includes the
superior frontal cortex and intraparietal cortex, that is involved in
the preparation and selection of stimuli and responses that have
a previous goal (67). In addition, the DLPFC has been shown to
be involved in inhibiting irrelevant sensory inputs (68). Deficits
in attention have been shown in individuals with PD that has
been associated to degeneration of noradrenergic cells as improve-
ment in neuropsychological tests of attention were observed with
clonidine treatment in PD (30). Furthermore, decreased cholin-
ergic function related to degeneration of the nucleus basilis of
Meynert (nbM) and pedunculopontine (PPN) nuclei that supply
the cerebral cortex and thalamo-striatal has been associated with
attentional dysfunction in PD (69). Importantly, synucleinopathic
degeneration of these cells precedes the nigral dopaminergic cell
loss that is the hallmark of PD pathology (57). The association
between these deficits and bimanual coordination is difficult to
untangle since several systems are likely involved in contributing
to coordination deficits in PD. Under normal circumstances of
bimanual coordination, individuals internally regulate attentional
resources to the sensory inputs (auditory cues, proprioceptive,
and visual information) to make appropriate responses. In addi-
tion, the sensory information received allows for the appropriate
responses to be selected and unwanted responses to be inhib-
ited. However, dysfunction in the regulation of attention to the
appropriate sensory information as well as inhibition of unwanted
sensory information leads to inappropriate responses. This may in
fact may have lead to the manifestation of amplitude impairments
in our PD patients that contributing to deficits in bimanual coor-
dination. This would be particularly evident during fast externally
paced anti-phase coordination when several sources of sensory
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information are available as the sensory information needs to be
processed more quickly with a greater attentional load. Thus, the
impairment is several neural pathways involving the basal ganglia,
ACC, DLPFC, and SMA likely all contribute to deficits in cued
bimanual anti-phase coordination when the frequency of move-
ment is increased and multiple sources of sensory feedback are
required to produce temporally and spatially precise movements.
There are several limitations of the current study. Firstly, mea-
sures of attention were not directly examined in the current sample
of PD patients. As a consequence, the association between impair-
ments in attention and deficits in bimanual coordination in PD
is theoretical in nature. Future studies should directly examine
attention as well as the amount of cholinergic and noradrenergic
dysfunction to verify if these associations to bimanual coordi-
nation impairments in PD patients are warranted. Secondly, the
cued dynamic increase in frequency within trials was sufficient
to circumvent the frequency impairments (bradykinesia) in our
PD patients. Although the current study was more focused on
determining the relationship between DOPA-responsive ampli-
tude (hypokinesia) and coordination impairments, future studies
that are concerned with DOPA-responsive frequency impairments
(bradykinesia) may benefit from evaluating self-paced rather than
externally cued movements. Finally, individuals with low motor
severity were removed from the majority of our analyses limiting
the generalizability of our findings to more severe PD patients.
However, based on our correlational analyses that found signifi-
cant correlations between the degree of coordination impairments
and motor severity as well as bradykinesia, caution should be used
in future bimanual coordination research that includes individuals
with PD with mild motor symptom severity.
CONCLUSION
The current results support that the dopaminergic system’s influ-
ence over specific spatiotemporal aspects of movement (such as
unilateral amplitude deficits) do not directly influence biman-
ual coordination performance. Based on the current results, the
demand on attentional resources imposed by anti-phase coordi-
nation and external auditory cueing may be important factors to
consider for their contribution to bimanual coordination deficits
in PD. Under certain conditions, internal timing deficits during
self-paced movements, impairments in sensorimotor integration
(when limiting compensatory sensory feedback), and/or dysfunc-
tional attentional processes may all contribute to bimanual coordi-
nation deficits in PD. Collectively, this would suggest that disperse
neural impairments are likely responsible for the coordination
impairments in PD that involve to some extent dopaminergic
system dysfunction, but also DOPA-resistant neural impairments
outside the dopaminergic system.
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APPENDIX
Table A1 | Statistical results from ANOVA analysis on planned comparison between PD “off” and healthy comparison (HC) participants and
between PD “off” and PD “on” to evaluate the effects of basal ganglia dysfunction on coordination accuracy and stability.
Factor(s) Coordination
accuracy
Main significant finding Coordination
stability
Main significant finding
Group F (1, 20)=12.46,
p<0.01*
Greater accuracy by HC F (1, 20)=12.29,
p<0.01*
Less variability by HC
Condition F (2, 40)=5.4,
p<0.01*
Greater accuracy in no vision and normal
vision
F (2, 40)=9.46,
p<0.001*
Less variability in no vision and normal
vision
Phase F (1, 20)=24.36,
p<0.001*
Greater accuracy in in-phase F (1, 20)=58.98,
p<0.001*
Less variability in in-phase
Required cycle
frequency
F (5, 100)=45.47,
p<0.001*
Greater accuracy at slower frequencies
(0.75, 1, and 1.25 Hz)
F (5, 100)=44.08,
p<0.001*
Less variability at slower frequencies
(0.75, 1, and 1.25 Hz)
Group×phase F (1, 20)=5.39,
p<0.05*
Greater accuracy by HC during anti-phase F (1, 20)=8.51,
p<0.01*
Less variability by HC during anti-phase
Group× required
cycle frequency
F (5, 100)=4.34,
p<0.01*
Greater accuracy by HC at fastest cycle
frequencies (1.75 and 2 Hz)
F (5, 100)=1.85,
p=0.11
N/A
Group×phase×
required cycle
frequency
F (5, 100)=2.83,
p<0.05*
See Section “Coordination Accuracy”
under Section “PD ‘Off’ vs. Healthy
Comparison Participants”
F (5, 100)=2.03,
p=0.08
N/A
Group× condition×
required cycle
frequency
F (10, 200)=0.4,
p=0.9
N/A F (10, 200)=2.54,
p<0.01*
See Section “Coordination Stability”
under Section “PD ‘Off’ vs. Healthy
Comparison Participants”
* denotes significance below p<0.05
Table A2 | Statistical results from ANOVA analysis on planned comparison between PD “off” and PD “on” to evaluate the effects of
dopaminergic treatment on coordination accuracy and stability.
Factor(s) Coordination
accuracy
Main significant finding Coordination
stability
Main significant finding
Session F (1, 10)=0.75,
p=0.4
N/A F (1, 10)=0.0.3,
p=0.9
N/A
Condition F (2, 20)=4.2,
p<0.05*
See Section “Coordination Accuracy” under
Section “PD ‘Off’ vs. PD ‘On”’
F (2, 20)=3.66,
p<0.05*
See Section “Coordination Stability” under
Section “PD ‘Off’ vs. PD ‘On”’
Phase F (1, 10)=23.93,
p<0.001*
Greater accuracy in in-phase F (1, 10)=56.97,
p<0.001*
Less variability in in-phase
Required cycle
frequency
F (5, 50)=25.46,
p<0.001*
Greater accuracy at slower frequencies
(0.75, 1, and 1.25 Hz)
F (5, 50)=26.39,
p<0.001*
Less variability at slower frequencies (0.75,
1, and 1.25 Hz)
* denotes significance below p<0.05
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Table A3 | Statistical results from ANOVA analysis on planned comparison between PD “off” and healthy comparison (HC) participants to
evaluate the effects of basal ganglia dysfunction on amplitude and frequency of movements.
Factor(s) Amplitude Main significant finding Cycle frequency Main significant finding
Group F (1, 20)=14.0,
p<0.01*
Larger amplitudes by HC F (1, 20)=0.01,
p=0.9
N/A
Limb F (1, 20)=0.07,
p=0.8
N/A F (1, 20)=0.2,
p=0.7
N/A
Condition F (2, 40)=15.17,
p<0.001*
Larger amplitudes in normal vision vs. no
vision and no vision vs. augmented vision
F (2, 40)=1.56,
p=0.2
N/A
Phase F (1, 20)=14.8,
p<0.01*
Larger amplitudes in in-phase F (1, 20)=5.19,
p<0.05*
Faster frequencies in in-phase
Required cycle
frequency
F (5, 100)=11.04,
p<0.001*
Smaller amplitude movements at slowest
frequency (0.75 Hz)
F (5, 100)=232.17,
p<0.001*
Cycle frequencies increased as required
frequency increased (except maintenance
between 1.25 and 1.5 Hz)
Group× required
cycle frequency
F (2, 40)=8.00,
p<0.001*
See Section “Mean Amplitude
(Affected/Less Affected Limbs PD ‘Off’
Compared to Matched Limbs)”
F (2, 40)=0.66,
p=0.7
N/A
Group× limb×
condition
F (2, 40)=5.69,
p<0.01*
See Section “Mean Amplitude
(Affected/Less Affected Limbs PD ‘Off’
Compared to Matched Limbs)”
F (2, 40)=0.034,
p=1.0
N/A
Group× limb×
required cycle
frequency
F (5, 100)=2.13,
p=0.07
N/A F (5,100)=3.51,
p<0.01*
See Section “Mean Performed Cycle
Frequency (Affected/Less Affected in PD
‘Off’ Compared to Matched Hands in
Healthy Comparisons)”
* denotes significance below p<0.05
Table A4 | Statistical results from ANOVA analysis on planned comparison between PD “off” and PD “on” to evaluate the effects of
dopaminergic treatment on amplitude and frequency of movements.
Factor(s) Amplitude Main significant finding Cycle frequency Main significant finding
Session F (1, 10)=0.46,
p=0.5
N/A F (1, 10)=0.49,
p=0.5
N/A
Limb F (1, 10)=4.68,
p=0.06
N/A F (1, 10)=0.35,
p=0.6
N/A
Condition F (2, 20)=3.76,
p<0.05*
Larger amplitudes in normal vision vs.
augmented
F (2, 20)=1.13,
p=0.3
N/A
Phase F (1, 10)=1.19,
p=0.3
N/A F (1, 10)=2.39,
p=0.2
N/A
Required cycle frequency F (5, 50)=3.87,
p<0.01*
Larger amplitudes at 1.25 vs. 1 Hz F (5, 50)=102.54,
p<0.001*
Cycle frequencies increased as
required frequency increased (except
maintenance between 1.25 and 1.5 Hz)
Session× required cycle
frequency
F (5, 50)=5.1,
p<0.001*
Larger amplitudes by PD “off” at
slowest frequencies (0.75 and 1 Hz)
F (5, 50)=0.59,
p=0.7
N/A
Session× limb×
condition
F (2, 20)=0.55,
p=0.6
N/A F (2, 20)=0.28,
p=0.8
N/A
Session× limb× required
cycle frequency
F (5, 50)=2.78,
p<0.05*
See Section “Mean Amplitude (More
Affected Compared to Less Affected)”
F (5, 50)=0.52,
p=0.8
N/A
* denotes significance below p<0.05
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Table A5 | Statistical results from ANOVA analysis on planned comparison between session 1 and session 2 of healthy comparison (HC)
participants to evaluate the effects of practice on coordination accuracy and stability.
Factor(s) Coordination
accuracy
Main significant finding Coordination
stability
Main significant finding
Session F (1, 10)=0.01,
p=0.9
N/A F (1, 10)=18.31,
p<0.01*
Less variability in session 2
Condition F (2, 20)=9.18,
p<0.01*
Greater accuracy in no vision
and normal vision
F (2, 20)=11.4,
p<0.001*
Less variability in no vision and normal vision
Phase F (1, 10)=14.6,
p<0.01*
Greater accuracy in in-phase F (1, 10)=20.51,
p<0.01*
Less variability in in-phase
Required cycle
frequency
F (5, 50)=33.64,
p<0.001*
Less accuracy at fastest
frequency (2 Hz)
F (5, 50)=51.03,
p<0.001*
More variability at fastest frequency (2 Hz)
Session× condition F (2, 20)=0.38,
p=0.7
N/A F (2, 20)=4.28,
p<0.05*
See Section “Coordination Stability” under Section
“Healthy Comparison Participants – Effects of Practice”
* denotes significance below p<0.05
www.frontiersin.org July 2013 | Volume 4 | Article 89 | 17
